Literature DB >> 16970558

Middle-aged and mobility-limited: prevalence of disability and symptom attributions in a national survey.

Elizabeth A Gardener1, Felicia A Huppert, Jack M Guralnik, David Melzer.   

Abstract

BACKGROUND: Lower limb mobility disabilities are well understood in older people, but the causes in middle age have attracted little attention.
OBJECTIVES: To estimate the prevalence of mobility disabilities among noninstitutionalized adults in England and to compare the disabling symptoms reported by middle-aged and older people.
DESIGN: Cross-sectional data from the 2002 English Longitudinal Study of Ageing (ELSA). Mobility disability was identified by level of reported difficulty walking a quarter mile. PARTICIPANTS: Eleven thousand two hundred sixteen respondents aged 50 years and older living in private households in 2002.
RESULTS: The prevalence of difficulty walking a quarter mile increases sharply with age, but even in the middle-aged (50 to 64 years age-group) 18% (95% confidence interval [CI]: 16% to 19%) of men and 19% (95% CI: 17% to 20%) of women reported some degree of difficulty. Of the 16 main symptoms reported as causing mobility disability in middle age, 2 dominated: pain in the leg or the foot (43%; 95% CI: 40% to 46%) and shortness of breath/dyspnea (21%; 95% CI: 18% to 23%). Fatigue or tiredness, and stability problems were cited by only 5% and 6%, respectively. These proportions were slightly different from those in the 65 to 79-year age group: 40%, 23%, 6%, and 8%, respectively.
CONCLUSIONS: Mobility (walking) disabilities in the middle-aged are relatively common. The symptoms reported as causes in this age group differ little from those reported by older groups, and are dominated by lower limb pain and shortness of breath. More clinical attention paid to disabling symptoms may lead to disability reductions in later life.

Entities:  

Mesh:

Year:  2006        PMID: 16970558      PMCID: PMC1831629          DOI: 10.1111/j.1525-1497.2006.00564.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  29 in total

1.  Performance tests and disability: developing an objective index of mobility-related limitation in older populations.

Authors:  Tzuo-Yun Lan; David Melzer; Brian D M Tom; Jack M Guralnik
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2002-05       Impact factor: 6.053

2.  The predictive validity for mortality of the index of mobility-related limitation--results from the EPESE study.

Authors:  David Melzer; Tzuo-Yun Lan; Jack M Guralnik
Journal:  Age Ageing       Date:  2003-11       Impact factor: 10.668

3.  Association between measures of morbidity and locomotor disability: diagnosis alone is not enough.

Authors:  Joy Adamson; Kate Hunt; Shah Ebrahim
Journal:  Soc Sci Med       Date:  2003-10       Impact factor: 4.634

Review 4.  Musculoskeletal aging.

Authors:  Suzanne G Leveille
Journal:  Curr Opin Rheumatol       Date:  2004-03       Impact factor: 5.006

5.  Walking difficulty, walking speed, and age as predictors of self-rated health: the women's health and aging study.

Authors:  M Jylhä; J M Guralnik; J Balfour; L P Fried
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-10       Impact factor: 6.053

Review 6.  Chronic illness management: what is the role of primary care?.

Authors:  Arlyss Anderson Rothman; Edward H Wagner
Journal:  Ann Intern Med       Date:  2003-02-04       Impact factor: 25.391

7.  Advancing the taxonomy of disability in older adults.

Authors:  Suzanne G Leveille; Linda P Fried; William McMullen; Jack M Guralnik
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2004-01       Impact factor: 6.053

Review 8.  Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report.

Authors:  Luigi Ferrucci; Jack M Guralnik; Stephanie Studenski; Linda P Fried; Gordon B Cutler; Jeremy D Walston
Journal:  J Am Geriatr Soc       Date:  2004-04       Impact factor: 5.562

9.  Disabling symptoms: what do older women report?.

Authors:  Suzanne G Leveille; Linda Fried; Jack M Guralnik
Journal:  J Gen Intern Med       Date:  2002-10       Impact factor: 5.128

10.  What does the medical record reveal about functional status? A comparison of medical record and interview data.

Authors:  S T Bogardus; V Towle; C S Williams; M M Desai; S K Inouye
Journal:  J Gen Intern Med       Date:  2001-11       Impact factor: 5.128

View more
  25 in total

1.  Respiratory symptoms, spirometric respiratory impairment, and respiratory disease in middle-aged and older persons.

Authors:  Brian S Marcus; Gail McAvay; Thomas M Gill; Carlos A Vaz Fragoso
Journal:  J Am Geriatr Soc       Date:  2015-01-30       Impact factor: 5.562

2.  Geriatric Syndromes in Older HIV-Infected Adults.

Authors:  Meredith Greene; Kenneth E Covinsky; Victor Valcour; Yinghui Miao; Joy Madamba; Harry Lampiris; Irena Stijacic Cenzer; Jeffrey Martin; Steven G Deeks
Journal:  J Acquir Immune Defic Syndr       Date:  2015-06-01       Impact factor: 3.731

3.  Adverse events associated with testosterone administration.

Authors:  Shehzad Basaria; Andrea D Coviello; Thomas G Travison; Thomas W Storer; Wildon R Farwell; Alan M Jette; Richard Eder; Sharon Tennstedt; Jagadish Ulloor; Anqi Zhang; Karen Choong; Kishore M Lakshman; Norman A Mazer; Renee Miciek; Joanne Krasnoff; Ayan Elmi; Philip E Knapp; Brad Brooks; Erica Appleman; Sheetal Aggarwal; Geeta Bhasin; Leif Hede-Brierley; Ashmeet Bhatia; Lauren Collins; Nathan LeBrasseur; Louis D Fiore; Shalender Bhasin
Journal:  N Engl J Med       Date:  2010-06-30       Impact factor: 91.245

4.  Measurement properties of the late life disability index among individuals who use power wheelchairs as their primary means of mobility.

Authors:  W Ben Mortenson; William C Miller; Jan Miller Polgar
Journal:  Arch Phys Med Rehabil       Date:  2014-06-07       Impact factor: 3.966

5.  Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation.

Authors:  Thomas G Travison; Shehzad Basaria; Thomas W Storer; Alan M Jette; Renee Miciek; Wildon R Farwell; Karen Choong; Kishore Lakshman; Norman A Mazer; Andrea D Coviello; Philip E Knapp; Jagadish Ulloor; Anqi Zhang; Brad Brooks; Ahn-Hoa Nguyen; Richard Eder; Nathan LeBrasseur; Ayan Elmi; Erica Appleman; Leife Hede-Brierley; Geeta Bhasin; Ashmeet Bhatia; Antonio Lazzari; Samuel Davis; Pengsheng Ni; Lauren Collins; Shalender Bhasin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-06-22       Impact factor: 6.053

6.  Social inequality in onset of mobility limitations in midlife: a longitudinal study in Denmark.

Authors:  Charlotte Juul Nilsson; Kirsten Avlund; Rikke Lund
Journal:  Eur J Ageing       Date:  2011-10-28

7.  Association of Functional Impairment in Middle Age With Hospitalization, Nursing Home Admission, and Death.

Authors:  Rebecca T Brown; L Grisell Diaz-Ramirez; W John Boscardin; Sei J Lee; Brie A Williams; Michael A Steinman
Journal:  JAMA Intern Med       Date:  2019-05-01       Impact factor: 21.873

8.  Exploratory Validation of a Multidimensional Power Wheelchair Outcomes Toolkit.

Authors:  W Ben Mortenson; Louise Demers; Paula W Rushton; Claudine Auger; Francois Routhier; William C Miller
Journal:  Arch Phys Med Rehabil       Date:  2015-09-25       Impact factor: 3.966

9.  Cross-Sectional Examination of Musculoskeletal Pain and Physical Function in a Racially and Socioeconomically Diverse Sample of Adults.

Authors:  Angie L Sardina; Alyssa A Gamaldo; Ross Andel; Shanthi Johnson; Tamara A Baker; Roland J Thorpe; Cathy McEvoy; Michele K Evans; Alan B Zonderman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-01-18       Impact factor: 6.053

10.  Development of a modified BODE index as a mortality risk measure among older adults with and without chronic obstructive pulmonary disease.

Authors:  Melissa H Roberts; Douglas W Mapel; Shannon Bruse; Hans Petersen; Toru Nyunoya
Journal:  Am J Epidemiol       Date:  2013-08-08       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.